Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Marco Volante Mauro Papotti Vito Amoroso Alfredo Berruti Nicola Fazio Lisa Bodei Anna Ferrero Luigi Dogliotti |
| Publication date | March 14, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |